• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Rexahn Pharmaceuticals, Inc. (RNN)

    -NYSE MKT
    0.61 Down 0.01(0.98%) Jul 2, 4:01PM EDT
    Add to Portfolio
    Prev Close:0.61
    Open:0.62
    Bid:0.59 x 100
    Ask:0.69 x 3000
    1y Target Est:2.58
    Beta:-1.87
    Next Earnings Date:N/A
    Day's Range:0.61 - 0.64
    52wk Range:0.60 - 0.96
    Volume:283,847
    Avg Vol (3m):603,194
    Market Cap:108.64M
    P/E (ttm):N/A
    EPS (ttm):-0.05
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RNN

    Comparison

    Symbol% ChgMkt Cap
    RNNDown 0.98%108.64M
    GSKUp 0.28%102.06B
    PFEDown 0.95%205.48B
    RHHBYUp 0.09%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.07
    Quarterly EPS Est (Jun-15) :-0.03
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes treatments for cancer and other medical needs. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback